ALLK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ALLK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the three months ended in Dec. 2023, Allakos paid $0.00 Mil more to buy back shares than it received from issuing new shares. It received $0.00 Mil from issuing more debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.00 Mil on other financial activities. In all, Allakos spent $0.00 Mil on financial activities for the three months ended in Dec. 2023.
The historical data trend for Allakos's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Allakos Annual Data | |||||||||||||||||
Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Cash Flow from Financing | Get a 7-Day Free Trial | 381.16 | 278.84 | 10.26 | 141.88 | 2.53 |
Allakos Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Cash Flow from Financing | Get a 7-Day Free Trial | 0.19 | 1.46 | - | 1.07 | - |
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Allakos's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:
Cash Flow from Financing | (A: Dec. 2023 ) | ||||||||||
= | Issuance of Stock | + | Repurchase of Stock | + | Net Issuance of Debt | + | Net Issuance of Preferred Stock | + | Cash Flow for Dividends | + | Other Financing |
= | 0.99 | + | 0 | + | 0 | + | 0 | + | 0 | + | 1.538 |
= | 2.53 |
Allakos's Cash from Financing for the quarter that ended in Dec. 2023 is:
Cash Flow from Financing | (Q: Dec. 2023 ) | ||||||||||
= | Issuance of Stock | + | Repurchase of Stock | + | Net Issuance of Debt | + | Net Issuance of Preferred Stock | + | Cash Flow for Dividends | + | Other Financing |
= | 0 | + | 0 | + | 0 | + | 0 | + | 0 | + | 0 |
= | 0.00 |
Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.53 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Allakos (NAS:ALLK) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Allakos's issuance of stock for the three months ended in Dec. 2023 was $0.00 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Allakos's repurchase of stock for the three months ended in Dec. 2023 was $0.00 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Allakos's net issuance of debt for the three months ended in Dec. 2023 was $0.00 Mil. Allakos received $0.00 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Allakos's net issuance of preferred for the three months ended in Dec. 2023 was $0.00 Mil. Allakos paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Allakos's cash flow for dividends for the three months ended in Dec. 2023 was $0.00 Mil. Allakos received $0.00 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Allakos's other financing for the three months ended in Dec. 2023 was $0.00 Mil. Allakos received $0.00 Mil on other financial activities.
Thank you for viewing the detailed overview of Allakos's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
Graham Neil Murray Hamilton | director | 33 MT. GREEN RD, CROTON ON HUDSON, NEW YORK NY 10520 |
Everett Rand Sutherland | director | 29 HARTWELL AVENUE, LEXINGTON MA 02421 |
Dolca Thomas | director | C/O PRINCIPIA BIOPHARMA INC., 220 E. GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080 |
Paul Edward Walker | director | 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093 |
Daniel Janney | director | PO BOX 7414, JACKSON WY 83002 |
Amy L Ladd | director | INTUITIVE SURGICAL, INC, 1020 KIFER RD, SUNNYVALE CA 94086 |
Craig A. Paterson | officer: Chief Medical Officer | ALLAKOS INC., 825 INDUSTRIAL ROAD, SUITE 500, SAN CARLOS CA 94070 |
Margaret Nell Fitzgerald | officer: General Counsel and Secretary | ALLAKOS INC., 825 INDUSTRIAL ROAD, SUITE 500, SAN CARLOS CA 94070 |
Steven P James | director | C/O OCERA THERAPUETICS, 525 UNIVERSITY AVENUE, SUITE 610, PALO ALTO CA 94301 |
Adam Tomasi | officer: COO, CFO and Secretary | ZS PHARMA, INC., 508 WRANGLER DRIVE, SUITE 100, COPPELL TX 75019 |
Robert Alexander | director, officer: President and CEO | 508 WRANGLER DRIVE, SUITE 100, COPPELL TX 75019 |
Harlan Baird Radford | officer: Chief Financial Officer | C/O EBAY INC., 2145 HAMILTON AVENUE, SAN JOSE CA 95125 |
Rasmussen Henrik S Md | officer: Chief Medical Officer | 508 WRANGLER DRIVE, SUITE 100, COPPELL TX 75019 |
John P Mckearn | director, 10 percent owner | 5820 NANCY DRIVE, SAN DIEGO CA 92121 |
Peter A Hudson | 10 percent owner | 701 COOL SPRINGS BOULEVARD, FRANKLIN TN 37067 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 02-01-2022
By PRNewswire • 01-23-2024
By Value_Insider Value_Insider • 11-07-2022
By sperokesalga sperokesalga • 06-12-2023
By Marketwired • 08-30-2023
By GuruFocusNews GuruFocusNews • 06-05-2022
By Value_Insider Value_Insider • 11-29-2022
By sperokesalga sperokesalga • 06-05-2023
By Marketwired • 08-02-2023
By Value_Insider Value_Insider • 11-10-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.